Skip to main content
. 2020 Nov 18;3(1):vdaa158. doi: 10.1093/noajnl/vdaa158

Table 2.

Shortened List of Univariate Assessments Between the Patients’ Characteristics and the Occurrence of SAO and EPS (for the full list with over 100 tested variables—see the Supplementary Table S1)

Parameter SAO EPS
OR (95% CI)/mean (±SD) P-value OR (95% CI)/mean (±SD) P-value
Age 61.24 (±12.16) vs 64.21 (±12.42) .001 63.62 (±13.49) vs 63.39 (±12.32) .677
Arterial hypertension 0.94 (0.69–1.27) .695 1.74 (1.02–2.96) .040
History of cancer 0.72 (0.46–1.14) .193 1.87 (1.03–3.40) .049
Location: parietal lobe 1.96 (1.28–3.01) .003 0.57 (0.22–1.44) .327
Location: frontal/temporal lobe 1.28 (0.93–1.76) .149 2.07 (1.15–3.75) .017
EOR: Surgery vs Biopsy 1.87 (1.30–2.68) .001 1.72 (0.92–3.21) .092
EOR: GTR vs Debulking 1.64 (1.15–2.35) .006 0.42 (0.23–0.76) .005
GFAP staining. ≥ 35% 1.88 (1.02–3.47) .053 0.91 (0.37–2.28) .812
KPS % continuous 83.16 (±12.19) vs 78.67 (±13.18) <.0001 78.09 (±13.74) vs 80.09 (±12.99) .304
Erythrocyte < 4.0/pL 2.12 (0.99–4.55) .079 4.28 (1.74–10.48) .004
WBC > 11/nL 0.40 (0.28–0.55) <.0001 1.09 (0.66–1.82) .796
Hemoglobin < 12 g/dL 1.43 (0.75–2.72) .285 3.34 (1.53–7.29) .005
Hematocrit < 35% 1.44 (0.70–2.94) .332 3.16 (1.33–7.55) .015
PLT > 400/nL 0.32 (0.11–0.90) .022 0.32 (0.04–2.34) .352
Sodium < 140 mmol/L 0.67 (0.49–0.94) .019 1.17 (0.70–1.97) .591
Chloride > 102 mmol/L 1.72 (1.22–2.42) .002 0.84 (0.50–1.43) .581
Calcium > 2.35 mmol/L 1.75 (1.24–2.46) .002 0.49 (0.26–0.95) .039
Urea > 20 mg/dL 0.53 (0.39–0.73) <.0001 1.62 (0.97–2.71) .068
GGT > 55 U/L 0.99 (0.67–1.47) 1.000 2.19 (1.26–3.81) .008
Total protein <7.0 g/dL 0.67 (0.48–0.92) .014 1.83 (1.05–3.18) .033
CRP >=1.0 mg/dL 0.96 (0.58–1.59) .898 3.00 (1.39–6.51) .006
PLT/WBC > 25 1.64 (1.20–2.24) .002 0.82 (0.50–1.38) .519
WBC/MPV < 0.9 2.69 (1.87–3.88) <.0001 1.12 (0.63–2.00) .768

CRP, C-reactive protein; EOR, extent of resection; GFAP, glial fibrillary acidic protein immunohistochemistry staining percentage; GGT, gamma-glutamyl-transferase; GTR, gross total resection; MPV, mean platelet volume; OR, odds ratio; PLT, blood platelets; SD, standard deviation; WBC, white blood cells. Differences with a P ≤ .05 were regarded as statistically significant.